MCLE

Medicale Corp.

USD

Set alert

Price alert · MCLE

All alert types
0.00 USD 0.00 0.00%
As of Oct 29, 2026
0.025 Day range 0.0265
0.0002 52-week range 6.18
YTD
-99.66%
1 year
-99.71%
Open
0.0265
Prev close
0.0004
Mkt cap
2.37K
Vol
10.00K
Avg vol
82
EPS
0.00
P/E
0.00
More statistics
Low
0.025
High
0.0265

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MCLE has not been loaded yet. Try again in a moment.

Financial health

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -21.6×
FY 2020: -10000×FY 2021: -556×FY 2022: -256×FY 2023: -68.8×FY 2024: -28.6×FY 2025: -21.6×
FY 2020 5y median -68.8× FY 2025
P/S 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -6.4×
FY 2020: -12659×FY 2021: -2126×FY 2022: -216×FY 2023: -64.0×FY 2024: -16.8×FY 2025: -6.4×
FY 2020 5y median -64.0× FY 2025
P/FCF -38.9×
FY 2020: -15815×FY 2021: -1000×FY 2022: -481×FY 2023: -101×FY 2024: -19.8×FY 2025: -38.9×
FY 2020 5y median -101× FY 2025
EV/EBITDA -29.9×
FY 2020: 840×FY 2021: -597×FY 2022: -284×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -29.9×
FY 2020 5y median -29.9× FY 2025
EV/Sales 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -2.6%
FY 2020: -0.0%FY 2021: -0.1%FY 2022: -0.2%FY 2023: -1.0%FY 2024: -5.0%FY 2025: -2.6%
FY 2020 5y median -1.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 29.4%
FY 2020: 137.1%FY 2021: 384.8%FY 2022: 84.7%FY 2023: 91.2%FY 2024: 58.8%FY 2025: 29.4%
FY 2020 5y median 84.7% FY 2025
ROIC 99.5%
FY 2020: 137.1%FY 2021: -981.7%FY 2022: 80.6%FY 2023: 92.4%FY 2024: 356.4%FY 2025: 99.5%
FY 2020 5y median 92.4% FY 2025
ROA 0.0%
FY 2020: -15.8%FY 2021: -113.7%FY 2022: -29194.3%FY 2023: -23357.2%FY 2024: -36611.9%FY 2025: 0.0%
FY 2020 5y median -23357.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 FY 2025
Operating Income 38.8%
FY 2020: 0.0%FY 2021: -1572.0%FY 2022: -36.9%FY 2023: 14.6%FY 2024: -45.5%FY 2025: 38.8%
FY 2020 FY 2025
EPS (diluted) 28.6%
FY 2020: 0.0%FY 2021: -1700.0%FY 2022: -44.4%FY 2023: 17.9%FY 2024: -53.1%FY 2025: 28.6%
FY 2020 FY 2025
Free Cash Flow 72.5%
FY 2020: 0.0%FY 2021: -1480.8%FY 2022: -38.7%FY 2023: -4.5%FY 2024: -224.7%FY 2025: 72.5%
FY 2020 FY 2025

Financial Health

Current Ratio 0.0×
FY 2020: 0.0×FY 2021: 0.5×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2020: 0.0×FY 2021: 0.5×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Debt / Equity -0.8×
FY 2020: 0.0×FY 2021: -1.4×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.8×FY 2025: -0.8×
FY 2020 5y median -0.8× FY 2025
Net Debt / EBITDA -3.2×
FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -3.2×
FY 2020 5y median 0.0× FY 2025
Interest Coverage -4.5×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -15.6×FY 2025: -4.5×
FY 2020 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30